Literature DB >> 7596331

Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alcoholics.

K M Cullen1, G M Halliday.   

Abstract

Tau immunoreactivity was examined in post mortem tissue from patients in three groups: neurologically-asymptomatic and neuropathologically normal alcoholics, alcoholics with Wernicke's Encephalopathy (WE) and age matched non-alcoholic controls. Tau-positive granular and fibrillary inclusions were frequently observed within the magnocellular neurons of the cholinergic nucleus basalis, within occasional nucleus basalis neurons in non-WE alcoholics, but not in controls. Tau immunoreactivity was not however observed in cortical, brainstem, diencephalic or non-cholinergic forebrain structures. Peroxidase activity was also examined within the nucleus basalis using diaminobenzidine as an indicator. The majority of neurons in the basal forebrain showed increased peroxidase activity in all WE alcoholics and in some nucleus basalis neurons of non-WE alcoholics, but was rarely seen in controls. Neighboring astrocytes also showed increased peroxidase activity. These results suggest a link between peroxidase activity and the abnormal accumulation of phosphorylated tau. The presence of tau in the nucleus basalis of alcoholics with WE suggests a thiamine-dependent mechanism in tau accumulation and cell death in the cholinergic basal forebrain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596331     DOI: 10.1007/BF01991785

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  45 in total

Review 1.  What's new in the pathology of neuronal cytoskeleton: the significance of neurofibrillary tangles.

Authors:  P Dustin; J P Brion; J Flament-Durand
Journal:  Pathol Res Pract       Date:  1992-02       Impact factor: 3.250

2.  Diminished blood selenium levels in alcoholics.

Authors:  B M Dworkin; W S Rosenthal; G G Gordon; R H Jankowski
Journal:  Alcohol Clin Exp Res       Date:  1984 Nov-Dec       Impact factor: 3.455

3.  Neuropathological correlates of memory dysfunction in the Wernicke-Korsakoff syndrome.

Authors:  G Halliday; K Cullen; A Harding
Journal:  Alcohol Alcohol Suppl       Date:  1994

4.  Neuronal counts from four cortical regions of alcoholic brains.

Authors:  J J Kril; C G Harper
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Low energy levels in thiamine-deficient encephalopathy.

Authors:  H Aikawa; I S Watanabe; T Furuse; Y Iwasaki; E Satoyoshi; T Sumi; T Moroji
Journal:  J Neuropathol Exp Neurol       Date:  1984-05       Impact factor: 3.685

6.  Okadaic acid enhances abnormal phosphorylation on tau proteins.

Authors:  Y Furiya; N Sahara; H Mori
Journal:  Neurosci Lett       Date:  1993-06-25       Impact factor: 3.046

7.  Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.

Authors:  S C Papasozomenos
Journal:  Lab Invest       Date:  1989-03       Impact factor: 5.662

8.  Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.

Authors:  S C Papasozomenos
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

9.  Glutamate increases tau phosphorylation in primary neuronal cultures from fetal rat cerebral cortex.

Authors:  P Sindou; M Lesort; P Couratier; C Yardin; F Esclaire; J Hugon
Journal:  Brain Res       Date:  1994-05-16       Impact factor: 3.252

10.  Extracellular glutamate is increased in thalamus during thiamine deficiency-induced lesions and is blocked by MK-801.

Authors:  P J Langlais; S X Zhang
Journal:  J Neurochem       Date:  1993-12       Impact factor: 5.372

View more
  9 in total

1.  Ethanol enhances tau accumulation in neuroblastoma cells that inducibly express tau.

Authors:  Tania F Gendron; Sharon McCartney; Ena Causevic; Li-Wen Ko; Shu-Hui Yen
Journal:  Neurosci Lett       Date:  2008-07-24       Impact factor: 3.046

Review 2.  Neuropathology of thiamine deficiency: an update on the comparative analysis of human disorders and experimental models.

Authors:  P J Langlais; S X Zhang; L M Savage
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

3.  Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease.

Authors:  M Gold; R A Hauser; M F Chen
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

Review 4.  Role of mitochondrial dysfunction and oxidative stress in the pathogenesis of selective neuronal loss in Wernicke's encephalopathy.

Authors:  Paul Desjardins; Roger F Butterworth
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

5.  Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency.

Authors:  N Y Calingasan; S E Gandy; H Baker; K F Sheu; J D Smith; B T Lamb; J D Gearhart; J D Buxbaum; C Harper; D J Selkoe; D L Price; S S Sisodia; G E Gibson
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

6.  Chronic alcoholism in the absence of Wernicke-Korsakoff syndrome and cirrhosis does not result in the loss of serotonergic neurons from the median raphe nucleus.

Authors:  K G Baker; G M Halliday; J J Kril; C G Harper
Journal:  Metab Brain Dis       Date:  1996-09       Impact factor: 3.584

Review 7.  Enhancing Rehabilitative Therapies with Vagus Nerve Stimulation.

Authors:  Seth A Hays
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

8.  Reduction of brain mitochondrial β-oxidation impairs complex I and V in chronic alcohol intake: the underlying mechanism for neurodegeneration.

Authors:  James Haorah; Travis J Rump; Huangui Xiong
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

Review 9.  The Inferior Colliculus in Alcoholism and Beyond.

Authors:  Tanuja Bordia; Natalie M Zahr
Journal:  Front Syst Neurosci       Date:  2020-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.